Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder

Name: Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder
Published: 2022
License: Public Domain

University Hospital, Basel, Switzerland · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

febrile neutropenia (fn), amikacin, hematological disorder, aminoglycoside (ag), area under the curve (auc), acute kidney injury (aki), pharmacokinetics and pharmacodynamics (pkpd) analysis, peak serum concentration (cmax), trough serum concentration (cmin), renal toxicity, pharmacological target attainment, amikacin concentration

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 991873
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.